What is the address of SORY MED?

The registered office of SORY MED is located at Rue Sous Ghoy(LAB) 53, 6567 Merbes-le-Château.

Is SORY MED still active?

Yes. According to the CBE (17 September 2026) SORY MED is active, legal situation “Normale toestand”, started on 28 November 2024.

Is SORY MED registered on Peppol?

No, SORY MED is currently not registered on the Peppol network.

What is the enterprise number of SORY MED?

The enterprise number of SORY MED is BE1016734204.

When was SORY MED founded?

SORY MED was founded on 28 November 2024.

Is SORY MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 November 2024; 2 annual accounts filed, latest fiscal year 2025.

How much profit did SORY MED make in 2025?

SORY MED posted a profit after taxes of € 79,381 in financial year 2025.

What is the revenue of SORY MED?

As a small company, SORY MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 121,788.

SORY MED (Private Limited) - Merbes-le-Château

Dossier SORY MED, printed on 17 September 2026 from databakkes.be/en/1016734204/sory-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

SORY MED from Merbes-le-Château, company number BE1016734204, closed financial year 2025 with a result of € 79,381 after tax. For that financial year SORY MED recorded a gross margin of € 121,788 and equity of € 89,745. Compared with financial year 2024, the result moved from € 7,030 to € 79,381. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Growing

€ 89,745

▲ € 78,548 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 79,381

▲ € 72,352 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 59,661

▲ € 58,253 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 833 paid out

1 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 85,377

Of which on lease € 84,592.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 67,081

€ 20,069 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 217

▼ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,828

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 8,827 Gross margin 2024: € 8,827 First fiscal year in the series	€ 121,788 Gross margin 2025: € 121,788 ▲ € 112,960 vs 2024 (€ 8,827) Favourable step	▲ € 112,960
Profit after taxes	€ 7,030 Profit after taxes 2024: € 7,030 First fiscal year in the series	€ 79,381 Profit after taxes 2025: € 79,381 ▲ € 72,352 vs 2024 (€ 7,030) Favourable step	▲ € 72,352
Equity	€ 11,196 Equity 2024: € 11,196 First fiscal year in the series	€ 89,745 Equity 2025: € 89,745 ▲ € 78,548 vs 2024 (€ 11,196) Favourable step	▲ € 78,548
Total debts	€ 15,335 Total debts 2024: € 15,335 First fiscal year in the series	€ 97,583 Total debts 2025: € 97,583 ▲ € 82,248 vs 2024 (€ 15,335) Unfavourable step	▲ € 82,248
Cash	€ 1,409 Cash 2024: € 1,409 First fiscal year in the series	€ 59,661 Cash 2025: € 59,661 ▲ € 58,253 vs 2024 (€ 1,409) Favourable step	▲ € 58,253
Retained profit	€ 6,196 Retained profit 2024: € 6,196 First fiscal year in the series	€ 84,745 Retained profit 2025: € 84,745 ▲ € 78,548 vs 2024 (€ 6,196) Favourable step	▲ € 78,548
Dividend	€ 833 Dividend 2024: € 833 First fiscal year in the series	€ 833 Dividend 2025: € 833 Unchanged (€ 833) Unchanged
Bank debt	€ 0 Bank debt 2024: € 0 First fiscal year in the series	€ 67,081 Bank debt 2025: € 67,081 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 26,531 Balance sheet total 2024: € 26,531 First fiscal year in the series	€ 187,328 Balance sheet total 2025: € 187,328 ▲ € 160,797 vs 2024 (€ 26,531) Unchanged	▲ € 160,797

Key figures of SORY MED, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SORY MED?

What happened at SORY MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 79,381 (▲ € 72,352 vs 2024). Source: NBB ↗
Nov 28, 2024 New establishment in Merbes-le-Château. KBO
Nov 28, 2024 Start of the company according to the CBE. KBO

In short

From € 7,030 profit in 2024 to € 79,381 profit in 2025.

Paid € 22,828 in corporate taxes since 2024.

Best year ever: 2025, with € 79,381 profit.

Paid out € 1,666 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at SORY MED? We notify you, reason included.

Follow SORY MED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Sous Ghoy(LAB) 53

6567 Merbes-le-Château

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SORY-MINTEN

€ 49,167 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1016.734.204
VAT number: BE 1016.734.204
Registered office: Rue Sous Ghoy(LAB) 53, 6567 Merbes-le-Château
Names & denominations: SORY MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 November 2024
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

SORY MED